Related Experiment Video
Updated: Oct 7, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Ten-Year Cardiovascular Disease Risk Trajectories by Obstetric History: A Longitudinal Study in the Norwegian HUNT
Abigail Fraser1,2, Amanda R Markovitz3,4,5,6, Eirin B Haug1,2,7
1Population Health Sciences Bristol Medical School University of Bristol Bristol UK.
Insights
Women with pregnancy complications do not require targeted cardiovascular disease (CVD) screening. However, these complications highlight individuals who would benefit from lifestyle changes to reduce future CVD risk.
Area of Science:
- Cardiovascular disease epidemiology
- Reproductive health
- Public health
Background:
- Women with a history of obstetric complications face elevated cardiovascular disease (CVD) risk.
- The necessity of specific CVD risk screening for these women remains undetermined.
Purpose of the Study:
- To investigate whether women with a history of obstetric complications should be specifically targeted for cardiovascular disease (CVD) risk screening.
Main Methods:
- Utilized linked data from the Norwegian HUNT Study and Medical Birth Registry of Norway.
- Created a population-based, prospective cohort of parous women.
- Applied a CVD risk prediction model to estimate 10-year CVD risk based on established risk factors.
Main Results:
- Predicted 10-year CVD risk scores were consistently higher in women aged 40–60 years with a history of obstetric complications.
- For example, at age 40, women with preeclampsia had a 0.06 percentage point higher mean risk score than those with normotensive deliveries.
- Differences in the proportion of women exceeding clinical thresholds for CVD counseling and treatment were modest.
Conclusions:
- Current findings do not support targeted CVD screening for parous women with pregnancy complications.
- Pregnancy complications identify women who would benefit from primordial and primary prevention strategies, including behavioral changes to mitigate later-life CVD risk.
Abstract:
Background Women with a history of obstetric complications are at increased risk of cardiovascular disease, but whether they should be specifically targeted for cardiovascular disease (CVD) risk screening is unknown. Methods and Results We used linked data from the Norwegian HUNT (Trøndelag Health) Study and the Medical Birth Registry of Norway to create a population-based, prospective cohort of parous women. Using an established CVD risk prediction model (A Norwegian risk model for cardiovascular disease), we predicted 10-year risk of CVD (nonfatal myocardial infarction, fatal coronary heart disease, and nonfatal or fatal stroke) based on established risk factors (age, systolic blood pressure, total and high-density lipoprotein cholesterol, smoking, antihypertensive use, and family history of myocardial infarction). Predicted 10-year CVD risk scores in women aged between 40 and 60 years were consistently higher in those with a history of obstetric complications. For example, when aged 40 years, women with a history of preeclampsia had a 0.06 percentage point higher mean risk score than women with all normotensive deliveries, and when aged 60 years this difference was 0.86. However, the differences in the proportion of women crossing established clinical thresholds for counseling and treatment in women with and without a complication were modest. Conclusions Findings do not support targeting parous women with a history of pregnancy complications for CVD screening. However, pregnancy complications identify women who would benefit from primordial and primary prevention efforts such as encouraging and supporting behavioral changes to reduce CVD risk in later life.
Related Concept Videos
Relative Risk
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Longitudinal Research
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Hazard Ratio
For example, in a clinical trial...

